Phocas Financial Corp. Neogenomics Inc Transaction History

Phocas Financial Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 17, 2018	SELL	$7.23 - $8.76 $3.57 Million - $4.33 Million	-494,104 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$8.02 - $11.18 $160,712 - $224,036	-20,039 Reduced 3.9%	494,104 $0
Q3 2017 Nov 17, 2017	BUY	$9.11 - $11.26 $4.68 Million - $5.79 Million	514,143	514,143 $6,000

296

125M

698K

116K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.77B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.